qSOFA Score Calculator

Quick Sequential Organ Failure Assessment — a bedside screening tool for identifying adult patients with suspected infection who may be at risk of poor outcomes, including sepsis-related organ dysfunction and in-hospital mortality.

Calculate qSOFA Score

Enter the three bedside criteria below for any adult patient with suspected infection. The qSOFA score is designed as a rapid screening prompt — it does not require laboratory testing and can be assessed in under a minute.

≥ 22 breaths/min scores 1 point · Normal: 12–20/min
GCS < 15 scores 1 point · Normal GCS: 15
≤ 100 mmHg scores 1 point · Normal: 100–140 mmHg
Low Risk (0) Intermediate (1) High Risk (2–3)
Important

The qSOFA is a screening prompt, not a diagnostic criterion for sepsis. A positive qSOFA (≥ 2) should trigger further assessment for organ dysfunction — typically via the full SOFA score and lactate measurement. A negative qSOFA does not exclude sepsis.

Understanding the qSOFA Score

The qSOFA (Quick SOFA) score was introduced as part of the Sepsis-3 consensus definitions in 2016 by Seymour et al. It was designed to address a key clinical need: a simple bedside tool that could rapidly identify patients with suspected infection who are at high risk of poor outcomes, without requiring laboratory results.

Prior to Sepsis-3, the Systemic Inflammatory Response Syndrome (SIRS) criteria were used to screen for sepsis. However, SIRS was criticised for being overly sensitive and poorly specific — up to 90% of ICU patients meet SIRS criteria at some point during their admission, and many non-infectious conditions (surgery, trauma, pancreatitis) trigger SIRS. The qSOFA was developed as a more specific prognostic tool for identifying patients at risk of sepsis-related death or prolonged ICU stay.

qSOFA Scoring Criteria

Each criterion scores 1 point (total range: 0–3):

1. Respiratory rate ≥ 22 breaths/min
2. Altered mentation (GCS < 15)
3. Systolic blood pressure ≤ 100 mmHg

Positive screen: qSOFA ≥ 2

Worked Example

A 72-year-old with urinary tract infection presents with:

RR: 26/min → +1
GCS: 13 (confused) → +1
SBP: 88 mmHg → +1

qSOFA = 3 → High risk. Proceed with full SOFA assessment, blood cultures, and lactate measurement.

qSOFA vs SIRS: The qSOFA is not a replacement for SIRS in all settings. Sepsis-3 retained SIRS for general awareness. qSOFA is specifically designed to predict poor outcomes (mortality, ICU stay ≥ 3 days) among patients with suspected infection — it is a prognostic tool, not a diagnostic definition.

Score Interpretation & Risk Stratification

The qSOFA score ranges from 0 to 3. A score of ≥ 2 is associated with a significantly increased risk of in-hospital mortality and prolonged ICU admission. The table below summarises the risk stratification based on the original Sepsis-3 validation data.

qSOFA ScoreRisk CategoryApprox. In-Hospital MortalityRecommended Action
0Low risk~1–2%Continue standard assessment; reassess if clinical status changes
1Intermediate risk~3–5%Heightened clinical vigilance; consider early investigations
2High risk~10–14%Assess for organ dysfunction (full SOFA); blood cultures + lactate
3Very high risk~20–25%Urgent full SOFA; initiate sepsis bundle; consider ICU referral
Clinical Pearl

The most common error with qSOFA is treating it as a sepsis definition. A qSOFA ≥ 2 does not diagnose sepsis — it identifies patients who warrant further assessment for organ dysfunction. Conversely, patients with qSOFA 0–1 can still have sepsis. Clinical judgement remains essential.

Sepsis Mimics & Differential Diagnosis

A positive qSOFA indicates physiological derangement — but not all patients meeting qSOFA criteria have sepsis. Several non-infectious conditions can produce tachypnoea, hypotension, and altered mentation. Identifying these mimics is critical to avoid inappropriate antibiotic administration and delayed treatment of the true underlying cause.

Acute heart failure, cardiogenic shock, and massive myocardial infarction can present with hypotension, tachypnoea, and altered mentation — all three qSOFA criteria. Key distinguishing features include an elevated jugular venous pressure, pulmonary oedema on chest radiograph, an S3 gallop, and a history of cardiac disease.

Point-of-care echocardiography is valuable: a severely reduced ejection fraction or significant regional wall motion abnormalities suggest a primary cardiac aetiology. Troponin and BNP/NT-proBNP can help differentiate, though these may also be elevated in severe sepsis.

Massive or submassive pulmonary embolism frequently presents with acute tachypnoea, hypotension, and syncope or altered consciousness. These patients may score ≥ 2 on qSOFA while having no infection whatsoever. Risk factors include recent surgery, immobilisation, malignancy, and oral contraceptive use.

The key diagnostic clues are acute-onset pleuritic chest pain, unilateral leg swelling, and hypoxia disproportionate to the chest radiograph findings. CT pulmonary angiography is the definitive investigation. D-dimer may help exclude PE in low-risk patients but is non-specific and often elevated in sepsis as well.

Acute blood loss — from gastrointestinal haemorrhage, trauma, ruptured aortic aneurysm, or ectopic pregnancy — causes hypotension and tachycardia with compensatory tachypnoea and, when severe, altered mentation. All three qSOFA criteria can be met in the absence of infection.

Serial haemoglobin monitoring, a focused history for blood loss, and FAST ultrasound in the emergency department can help identify a haemorrhagic source. In patients with both haemorrhage and infection (e.g., perforated viscus), both processes must be addressed simultaneously.

Diabetic ketoacidosis (DKA) classically produces Kussmaul breathing (deep, rapid respirations), which can score on the respiratory rate criterion. Hypotension from dehydration and altered mentation from cerebral oedema or acidosis may fulfil all three qSOFA criteria. Check blood glucose, ketones, and a venous blood gas.

Drug overdoses — particularly opioids, benzodiazepines, tricyclic antidepressants, and sympathomimetics — can produce altered consciousness, respiratory depression or tachypnoea, and haemodynamic instability. A thorough medication and substance use history is essential. Salicylate toxicity specifically causes a mixed respiratory alkalosis and metabolic acidosis with tachypnoea.

Stroke — both ischaemic and haemorrhagic — can cause altered mentation (GCS < 15) and may produce autonomic instability with hypotension or hypertension. Subarachnoid haemorrhage in particular can present with a reduced GCS, tachypnoea, and neurogenic stunned myocardium causing hypotension.

Status epilepticus, meningoencephalitis, and intracranial mass lesions with raised intracranial pressure all cause altered mentation and potentially Cushing’s response (hypertension, bradycardia, irregular respiration) — although the last of these may be misread as tachypnoea if respiration is irregular. Always perform a focused neurological examination.

Anaphylaxis produces distributive shock with hypotension, tachypnoea (from bronchospasm or laryngeal oedema), and altered mentation from cerebral hypoperfusion — potentially meeting qSOFA ≥ 2. The hallmark features are urticaria, angioedema, wheezing, and a clear temporal relationship to allergen exposure.

Adrenal crisis is another form of distributive shock: profound hypotension, altered mentation, and compensatory tachypnoea in a patient with known adrenal insufficiency or chronic steroid use. Random cortisol and ACTH levels are diagnostic. Neurogenic shock from spinal cord injury presents with hypotension and bradycardia — the bradycardia helps distinguish it from other shock states.

Bedside Approach

When qSOFA is positive, ask: “Is there a clear source of infection?” If yes, proceed with the sepsis pathway. If no, systematically consider cardiac, haemorrhagic, pulmonary, metabolic, neurological, and anaphylactic causes before attributing the physiological derangement to sepsis alone.

Special Populations & Considerations

The qSOFA was derived and validated primarily in adult patients with suspected infection in emergency department and ward settings. Its performance varies across specific populations, and these limitations should inform clinical decision-making.

65+
Elderly Patients

Older adults often have lower baseline blood pressures and may present with atypical infection manifestations — including confusion as the sole sign. A GCS of 14 in a previously alert 85-year-old is highly significant and should not be dismissed. qSOFA may be more sensitive in this population but should prompt early full SOFA assessment.

ICU
ICU Patients

The qSOFA was specifically designed for patients outside the ICU. In critically ill ICU patients, the full SOFA score is the recommended tool for assessing sepsis-related organ dysfunction. Many ICU patients meet qSOFA criteria at baseline due to sedation, mechanical ventilation, or vasopressor use, reducing the tool’s discriminative value.

🤰
Pregnancy

Pregnant patients have physiological changes that affect qSOFA criteria: a higher resting respiratory rate (up to 20–24/min by the third trimester) and lower systolic blood pressure (by 5–10 mmHg in mid-pregnancy). These normal changes may cause false-positive qSOFA results. The omission of Obstetric Early Warning Score (OEWS) parameters is a recognised limitation.

🧠
Baseline Neurological Impairment

Patients with pre-existing cognitive impairment — dementia, learning disability, or prior stroke — may have a baseline GCS < 15. In these patients, altered mentation should be assessed relative to their usual baseline, not a normative GCS of 15. Document baseline GCS clearly to allow meaningful reassessment.

Paediatric Note: The qSOFA has not been validated in children. Paediatric sepsis screening uses age-specific vital sign thresholds (e.g., the paediatric SIRS criteria or the 2024 Phoenix Sepsis criteria). Do not apply qSOFA to patients under 18 years of age.

Common Pitfalls & Limitations

The qSOFA is a useful screening tool but carries important limitations. Understanding these pitfalls helps avoid both over-reliance and under-utilisation of the score in clinical practice.

The most frequent misunderstanding is equating qSOFA ≥ 2 with a diagnosis of sepsis. The Sepsis-3 definition of sepsis requires life-threatening organ dysfunction caused by a dysregulated host response to infection, assessed by a SOFA score increase of ≥ 2. qSOFA is a prompt to investigate further — not a diagnostic endpoint.

This distinction matters clinically: a patient with qSOFA of 2 due to pneumonia may have sepsis, but a patient with qSOFA of 2 due to acute heart failure exacerbation does not. The full SOFA score, combined with clinical suspicion of infection and source identification, is needed to confirm sepsis.

A qSOFA of 0 or 1 does not exclude sepsis. Several studies — including Churpek et al. (2017) — have shown that the sensitivity of qSOFA for predicting in-hospital mortality is lower than SIRS or the Modified Early Warning Score (MEWS), particularly in the emergency department. Patients with early or compensated sepsis may have a normal blood pressure, preserved mentation, and only mild tachypnoea.

If clinical suspicion for infection is high — based on history, examination, or inflammatory markers — the clinician should proceed with a full sepsis workup regardless of the qSOFA result. The score should never override clinical judgement.

The qSOFA is typically calculated once at presentation. However, sepsis is a dynamic process, and vital signs can deteriorate rapidly. A patient with qSOFA 1 at triage may progress to qSOFA 3 within hours. Serial reassessment is important, particularly in patients with suspected but unconfirmed infection.

Incorporating qSOFA into nursing early warning score documentation — or reassessing at set intervals (e.g., every 2–4 hours) — can improve its utility as a monitoring tool rather than a one-off screening test.

Patients with chronic conditions may meet qSOFA criteria at their baseline. A patient with COPD may chronically have a respiratory rate of 22–24. A patient with chronic kidney disease on antihypertensives may have a baseline systolic BP of 95 mmHg. Patients with dementia often have a GCS below 15.

In these populations, the qSOFA should be interpreted relative to the patient’s known baseline, not absolute thresholds. A change from baseline — rather than an absolute value — is more clinically meaningful. Unfortunately, the binary nature of the qSOFA criteria does not accommodate this nuance, and clinician judgement must compensate.

Multiple external validation studies have demonstrated that while qSOFA has reasonable specificity for predicting mortality, its sensitivity is lower than alternative screening tools. Freund et al. (2017) found that qSOFA had a sensitivity of approximately 70% for in-hospital mortality compared with 90% for SIRS in ED patients with suspected infection.

The National Early Warning Score (NEWS/NEWS2) may outperform qSOFA for early identification of deterioration in ward patients. Many institutions use NEWS as the primary screening tool and reserve qSOFA or SOFA for targeted sepsis assessment. The optimal approach depends on institutional protocols and clinical setting.

Limitation

The qSOFA does not include temperature, heart rate, white cell count, or lactate — all of which are important markers of infection and sepsis severity. A patient with a temperature of 40°C, heart rate of 130 bpm, and a WCC of 25 × 10⁹/L may still have a qSOFA of 0 if blood pressure, respiratory rate, and mentation are preserved. Always consider the full clinical picture.

Quick Reference Summary

3 Bedside criteria
(no labs required)
≥ 2 Positive screen
(assess for organ dysfunction)
3–10× Increased mortality risk
(qSOFA ≥ 2 vs 0)
< 1 min Time to calculate
(at the bedside)
CriterionThresholdPoints
Respiratory rate≥ 22 breaths/min1
Altered mentationGCS < 151
Systolic blood pressure≤ 100 mmHg1

The Golden Rule: qSOFA ≥ 2 is a prompt to act, not a diagnosis. It triggers further assessment — full SOFA score, blood cultures, serum lactate, and clinical review for source of infection. A negative qSOFA never overrides clinical concern for sepsis.

Disclaimer & References

Disclaimer

For Educational Purposes Only. This calculator and the accompanying clinical information are intended as educational tools for healthcare professionals. They do not replace clinical judgement. Results should be interpreted in the full clinical context. Lab reference ranges vary by institution — verify with your own laboratory. Drug dosages should be confirmed against current prescribing information.

References

  1. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–810. DOI: 10.1001/jama.2016.0287
  2. Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):762–774. DOI: 10.1001/jama.2016.0288
  3. Freund Y, Lemachatti N, Krastinova E, et al. Prognostic Accuracy of Sepsis-3 Criteria for In-Hospital Mortality Among Patients With Suspected Infection Presenting to the Emergency Department. JAMA. 2017;317(3):301–308. DOI: 10.1001/jama.2016.20329
  4. Raith EP, Udy AA, Bailey M, et al. Prognostic Accuracy of the SOFA Score, SIRS Criteria, and qSOFA Score for In-Hospital Mortality Among Adults With Suspected Infection Admitted to the Intensive Care Unit. JAMA. 2017;317(3):290–300. DOI: 10.1001/jama.2016.20328
  5. Churpek MM, Snyder A, Han X, et al. Quick Sepsis-related Organ Failure Assessment, Systemic Inflammatory Response Syndrome, and Early Warning Scores for Detecting Clinical Deterioration in Infected Patients outside the Intensive Care Unit. Am J Respir Crit Care Med. 2017;195(7):906–911. DOI: 10.1164/rccm.201604-0854OC
  6. Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200–211. DOI: 10.1016/S0140-6736(19)32989-7
  7. Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med. 2021;49(11):e1063–e1143. DOI: 10.1097/CCM.0000000000005337
  8. Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):775–787. DOI: 10.1001/jama.2016.0289